
Development of novel agents for bladder cancer
Keywords: PI3 کیناز; Bladder Cancer; Novel Agents; Chemotherapy; Angiogenesis; Epigenetics; HER-2; EGFR; NFκB; PI3 kinase; Clinical Trial Design